Latest Articles

Publication Date
Response to the Letter: Observations and points of interest regarding bioinformatics predictions of miRNA targeting syncytin genes in endometriosis and miscarriage.

Published: May 9, 2026, midnight
Observations and points of interest regarding bioinformatics predictions of miRNA targeting syncytin genes in endometriosis and miscarriage.

Published: May 9, 2026, midnight
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment - The American Journal of Managed Care® (AJMC®)

Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment The American Journal of Managed Care® (AJMC®)

Published: May 8, 2026, 4:51 p.m.
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment - AJMC

Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment AJMC

Published: May 8, 2026, 4:51 p.m.
Histone Deacetylase 10 Inhibitors Suppress Progression of Endometriosis via Activation of Interferon Regulatory Factor 6 and Dachshund Homolog 1.

To investigate the mechanisms of histone deacetylase (HDAC) 10 inhibitors (HDAC10Is) action in endometriosis and the target molecules of HDAC10Is.

Published: May 8, 2026, midnight
Targeting the Wnt signaling network in endometriosis: mechanistic insights and translational opportunities.

Endometriosis is a chronic gynecological disorder defined by the growth of endometrial-like tissue outside the uterus, driven by estrogen-dependent inflammation and progressive fibrosis. According to available data, remodeling and persistent …

Published: May 8, 2026, midnight
Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.
FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

FDA clears new dual-target cancer drug for ovarian, endometrial trial Stock Titan

Published: May 7, 2026, 12:02 p.m.
Microbiome in women with endometriosis and the in vitro effects of Lactobacillus reuteri on human endometrium.

Endometriosis (EMS) is a chronic inflammatory disorder affecting ~10% of reproductive-age women, with increasing evidence implicating the microbiome in its pathogenesis through immunomodulation and estrogen metabolism. This study investigated microbiome …

Published: May 6, 2026, midnight
New Endometrial Targets Beyond HER2 - OncLive

New Endometrial Targets Beyond HER2 OncLive

Published: May 5, 2026, 12:06 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!